Generics 20

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Fludarabine phosphate manufacturers

20 products found

Filters

20 products found

fludarabine phosphate

Vials, injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

This CTD dossier owner and manufacturer is a leading manufacturer of anti-cancer medications, specializing in a wide range of oncology drugs including those for solid tumors, hematology, and supportive care. They boast a portfolio of over 100 products with a focus on cost-effectiveness through in-house API development and manufacturing. The company's commitment to innovation is evident in their New Drug Delivery System (NDDS) formulations which aim to improve patient compliance and reduce medication waste. Their strong R&D pipeline promises further advancements in the oncology field. They hold WHO-GMP certifications for their API plant, enabling both domestic and international market reach. Key therapy areas include AML, Renal Cell Carcinoma, Gastro-Intestinal tumors, Pancreatic Neuroendocrine Tumors, Thyroid cancer, and Prostate cancer.

Manufacturer usually replies in 5 days

fludarabine phosphate

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19783
This pharmaceutical company specializes in the development and production of a wide range of generic and branded medications. Their manufacturing facility, located in an excise-free zone, is WHO-GMP certified and adheres to MHRA UK and TGA standards. They offer various dosage forms, including tablets, capsules, oral liquids, dry syrups, parenterals, MDIs, powders, and ointments. The company focuses on several key therapy areas such as antibiotics, anti-inflammatories, cardiovascular medications, anti-diabetic drugs, oncology products, and vitamins. They export their products to regions including Central Asia and the Caucasus.

Manufacturer usually replies in 2 days

fludarabine phosphate

Injection, lyophilized 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064

Established in 1970, this Chinese manufacturer specializes in the research, development, production, and sales of a wide range of pharmaceutical products. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates advanced production lines across four industrial parks, covering approximately 1,333,400 square meters, and employs nearly 5,000 individuals, including over 2,000 professional and technical personnel. Its diverse product portfolio includes anesthetic agents, psychotropic medicines, nonsteroidal anti-inflammatory drugs, cardiovascular system medicines, antibiotics, and antiviral medicines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide. The manufacturer holds GMP certifications from international regulatory authorities, including the U.S. FDA and the Philippines FDA, ensuring adherence to stringent global quality standards

Manufacturer usually replies in 5 days

Want to see all 20 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible